Achieving 90-90-90 Human Immunodeficiency Virus (HIV) Targets Will Not Be Enough to Achieve the HIV Incidence Reduction Target in Australia.

Scott N, Stoové M, Kelly SL, Wilson DP, Hellard ME

The case for a universal hepatitis C vaccine to achieve hepatitis C elimination.

Scott N, Wilson DP, Thompson AJ, Barnes E, El-Sayed M, Benzaken AS, Drummer HE, Hellard ME

Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.

Schröeder SE, Pedrana A, Scott N, Wilson D, Kuschel C, Aufegger L, Atun R, Baptista-Leite R, Butsashvili M, El-Sayed M, Getahun A, Hamid S, Hammad R, 't Hoen E, Hutchinson SJ, Lazarus JV, Lesi O, Li W, Binti Mohamed R, Olafsson S, Peck R, Sohn AH, Sonderup M, Spearman CW, Swan T, Thursz M, Walker T, Hellard M, Howell J

Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.

Tordrup D, Hutin Y, Stenberg K, Lauer JA, Hutton DW, Toy M, Scott N, Bulterys M, Ball A, Hirnschall G

A framework for assessing local transmission risk of imported malaria cases.

Lei L, Richards JS, Li ZH, Gong YF, Zhang SZ, Xiao N

Global Infectious Disease Threats Infectious Disease Modelling Infectious Disease Surveillance

Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia.

Doyle JS, Scott N, Sacks-Davis R, Pedrana AE, Thompson AJ, Hellard ME, Eliminate Hepatitis C Partnership